VCI Global Secures Its First IPO Consultancy Deal in 2024 With a Singapore-Based Fin-MedTech Medical Group
KUALA LUMPUR, Malaysia, Jan. 23, 2024 (GLOBE NEWSWIRE) — VCI Global Limited (NASDAQ:VCIG) (“VCI Global”, or the “Company”) has been engaged by a Singapore-based Fin-MedTech Medical Group (the “Medical Group”) as its initial public offering (“IPO”) consultant for its intended IPO on Nasdaq which is expected to be completed in 2024/2025.
Related news for (VCIG)
- Don’t Miss Out: MoBot’s Latest Stock Updates 10/23/25 09:00 AM
- VCI Global Subsidiary Smart Bridge to Launch Ethereum-Based, Gold-Backed Crypto-Fiat Platform
- 24/7 Market News Snapshot 23 October, 2025 – VCI Global Limited Ordinary Share (NASDAQ:VCIG)
- Powering Up AI Infrastructure and Power Cords
- VCI Global Issues Full-Year 2025 Guidance with 70% Revenue Growth Target Driven by AI, Cybersecurity, Fintech, and GPU Cloud Expansion
